The Securities and Exchange Board of India (Sebi) on Tuesday debarred Gautam Thapar, the ousted chairman of fraud-hit CG Power and Industrial Solutions, from accessing the capital market for a number of alleged irregularities, including diversion of money.

Shares of Equitas Holdings slipped 17 per cent to Rs 97 on the BSE on Monday after the Securities and Exchange Board of India (Sebi) on Friday returned the draft scheme with regard to Equitas Small Finance Bank (ESFB), citing that it was not in compliance with the regulatory provisions.

Market regulator Securities and Exchange Board of India (Sebi) on Friday returned the scheme of arrangement mooted by Chennai-based Equitas Holdings with regard to Equitas Small Finance Bank, citing that draft scheme was not in compliance with the regulatory provisions.

In filing to stock exchanges, Equitas Holdings, promoter of ESFB, said it will initiate necessary steps to list its shares through Initial Public Offer (IPO)which is expected to be completed by March 2020 under normal circumstances.

Sebi on Thursday asked listed companies to settle their outstanding dues with the capital markets regulator, bourses and depositories before filing “schemes of arrangement” such as mergers and demergers with the exchanges.

The markets regulator also said listed entities will be liable for punitive action in case of furnishing any false information.

Markets regulator Sebi has levied a fine of Rs 6 lakh on sub-broker SRU Securities for indulging in manipulative trading in the shares of Cerebra Integrated Technologies.

The order follows an investigation conducted by the Securities and Exchange Board of India (Sebi) between December 2014 and January 2016.

Mumbai: In a major setback to Sebi, Securities Appellate Tribunal or SAT today overturned the markets regulator's order banning Price Waterhouse Coopers from auditing any listed company for two years for its role in the ₹7,800-crore Satyam scam. However, SAT partly allowed disgorgement of the ₹13 crore fee from the auditor.

New Delhi: Drug major Sun Pharmaceutical Industries on Thursday said a forensic audit has been ordered by markets regulator Sebi with regard to its financial statements for three financial years between 2015-16 and 2017-18.

In a regulatory filing, Sun Pharma said, "A forensic audit has been ordered by Sebi w.r.t. the financial statements of Sun Pharmaceutical Industries Ltd for the financial years ending March 31, 2016, March 31, 2017 and March 31, 2018".

Markets regulator Sebi has reconstituted its Primary Market Advisory Committee (PMAC) that advises it on policy framework and development of initial public offerings and other such segments.

The 23-member panel is chaired by T V Mohandas Pai, chairman of the Manipal Global Education Services, according to the Securities and Exchange Board of India (Sebi).

The Securities and Exchange Board of India (Sebi), in its order on Thursday, disposed of the show cause notice (SCN) issued to senior employees of the National Stock Exchange (NSE) on January 4, with respect to the co-location (colo) case. The capital markets regulator did not levy any monetary penalty.

Markets regulator Sebi has told the mutual fund industry that safety of investment cannot be compromised for higher yields.

Speaking at the Association of Mutual in India (Amfi) members summit in Mumbai on Tuesday, Securities and Exchange Board of India chairman Ajay Tyagi also added that, the industry as a whole needs to do its own analysis on a regular basis to avoid such situations in future.

Inviting Real Estate Agents, Job Placements Agents, Educational Institutes, Software Service Providers, Real Estate Builders, Marriage Bureaus, Travel Agents, Restaurant Owners, Health & Fitness Centers and other Local Businesses to Post a FREE Classified Advertisement on Cootera.com Classifieds Website.